Benzinga | Apr 29, 2021 06:09AM EDT

West Pharmaceutical Servs Q1 Adj. EPS $2.05 Beats $1.43 Estimate, Sales $670.70M Beat $611.39M Estimate; Raises Guidance

West Pharmaceutical Servs (NYSE:WST) reported quarterly earnings of $2.05 per share which beat the analyst consensus estimate of $1.43 by 43.36 percent. This is a 102.97 percent increase over earnings of $1.01 per share from the same period last year. The company reported quarterly sales of $670.70 million which beat the analyst consensus estimate of $611.39 million by 9.70 percent. This is a 36.46 percent increase over sales of $491.50 million the same period last year.